Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGLL | Q99685 | 10/20 | 0.62 |
| ▸ | FAAH | O00519 | 5/20 | 0.62 |
| ▸ | PTGS1 | P23219 | 7/20 | 0.60 |
| ▸ | PTGS2 | P35354 | 7/20 | 0.60 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.60 |
| ▸ | LMNA | P02545 | 2/20 | 0.60 |
| ▸ | MAPT | P10636 | 2/20 | 0.60 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.60 |
| ▸ | HPGD | P15428 | 2/20 | 0.60 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.60 |
| ▸ | TLR9 | Q9NR96 | 1/20 | 0.60 |
| ▸ | TP53 | P04637 | 1/20 | 0.60 |
| ▸ | PKM | P14618 | 1/20 | 0.60 |
| ▸ | XBP1 | P17861 | 1/20 | 0.60 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.60 |
| ▸ | HTT | P42858 | 1/20 | 0.60 |
| ▸ | RECQL | P46063 | 1/20 | 0.60 |
| ▸ | RAB9A | P51151 | 1/20 | 0.60 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.60 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5665936 | 0.92 | PTGS1 (0.72) | MGLLFAAHPTGS1PTGS2ALDH1A1 | |
| SCHEMBL1704532 | 0.83 | MGLL (0.62) | MGLLFAAHPTGS1PTGS2ALDH1A1 | |
| SCHEMBL155346 | 0.83 | PTGS1 (0.85) | MGLLFAAHPTGS1PTGS2ALDH1A1 | |
| SCHEMBL10014802 | 0.81 | MGLL (0.60) | MGLLFAAHPTGS1PTGS2ALDH1A1 | |
| SCHEMBL22009102 | 0.81 | MGLL (0.60) | MGLLFAAHPTGS1PTGS2ALDH1A1 | |
| Hydrochloric Acid SCHEMBL17924135 | 0.81 | PTGS1 (0.81) | MGLLFAAHPTGS1PTGS2ALDH1A1 | |
| SCHEMBL3047985 | 0.81 | PTGS1 (0.81) | MGLLFAAHPTGS1PTGS2ALDH1A1 | |
| SCHEMBL3049679 | 0.81 | PTGS1 (0.81) | MGLLFAAHPTGS1PTGS2ALDH1A1 | |
| SCHEMBL6473262 | 0.81 | PTGS1 (0.81) | MGLLFAAHPTGS1PTGS2ALDH1A1 | |
| SCHEMBL17764749 | 0.81 | PTGS1 (0.81) | MGLLFAAHPTGS1PTGS2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2014065861-A1 | COMPOSITIONS, METHODS AND MICROFLUIDICS DEVICE FOR TELOMERASE BASED IN VITRO DIAGNOSTIC ASSAYS FOR DETECTING CIRCULATING TUMOR CELLS (CTC) | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2014-05-01 | — | — | WO | claimed |
| EP-4192493-A1 | IMMUNOGENIC COMPOUNDS | AC Immune SA (CH) | 2023-06-14 | — | — | EP | disclosed |
| CN-108368538-A | METHOD FOR GENERATING PROXIMITY PROBES | 欧凌科蛋白质公司 | 2018-08-03 | — | — | CN | disclosed |
| WO-2017143344-A1 | INJECTABLE NANOMATERIAL-EXTRACELLULAR MATRIX CONSTRUCTS | THE CURATORS OF THE UNIVERSITY OF MISSOURI (US) | 2017-08-24 | — | — | WO | disclosed |
| CN-103597089-B | method for enzyme-mediated signal amplification | 丹麦达科有限公司 | 2017-04-12 | — | — | CN | disclosed |
| US-9573983-B2 | Compositions including I-domain antigen conjugate compounds and methods for treatment of autoimmune disorders | UNIVERSITY OF KANSAS (US) | 2017-02-21 | — | — | US | disclosed |
| WO-2015133680-A1 | METHOD FOR MEASURING PROTEIN KINASE ACTIVITY AND KIT FOR SAME | 주식회사 아모그린텍 | 2015-09-11 | — | — | WO | disclosed |
| EP-2885318-A1 | PEPTIDE-DENDRIMER CONJUGATES AND USES THEREOF | Angiochem Inc. (CA) | 2015-06-24 | — | — | EP | disclosed |
| CN-102911864-B | Separator for rare cells in blood | Ningbo meijing medical technology co ltd | 2014-08-06 | — | — | CN | disclosed |
| WO-2014026283-A1 | PEPTIDE-DENDRIMER CONJUGATES AND USES THEREOF | ANGIOCHEM INC. (CA) | 2014-02-20 | — | — | WO | disclosed |
| WO-2004081045-A2 | VACCINE RELATED TO MODIFIED APOLIPOPROTEIN C-III | GLAXOSMITHKLINE BIOLOGICALS S.A. (BE) | 2004-09-23 | — | — | WO | disclosed |
| EP-1421116-A2 | VACCINE THERAPIES AND PROPHYLACTIC TREATMENTS OF ATHEROSCLEROTIC DISEASES | GlaxoSmithKline Biologicals S.A. (BE) | 2004-05-26 | — | — | EP | disclosed |
| EP-1417221-A2 | MIMOTOPE OF NEISSERIA MENINGITIDIS LIPOOLIGOSACCHARIDE AND VACCINES CONTAINING THE SAME | GlaxoSmithKline Biologicals S.A. (BE) | 2004-05-12 | — | — | EP | disclosed |
| EP-1343526-A2 | VACCINE | SMITHKLINE BEECHAM PLC (GB) | 2003-09-17 | — | — | EP | disclosed |
| WO-2003020765-A2 | VACCINE THERAPIES AND PROPHYLACTIC TREATMENTS OF ATHEROSCLEROTIC DISEASES | GLAXOSMITHKLINE BIOLOGICALS S.A. (BE) | 2003-03-13 | — | — | WO | disclosed |
| WO-2003000176-A2 | CONJUGATES OF REDUCED ANTIBODIES AND BIOMOLECULES | MOLECULAR STAGING, INC. (US) | 2003-01-03 | — | — | WO | disclosed |
| EP-1267908-A1 | VACCINE FOR THE TREATMENT OF ATHEROSCLEROSIS | SMITHKLINE BEECHAM BIOLOGICALS s.a. (BE) | 2003-01-02 | — | — | EP | disclosed |
| WO-2002049667-A2 | VACCINE FOR TREATING NICOTINE ADDICTION | SMITHKLINE BEECHAM P.L.C (GB) | 2002-06-27 | — | — | WO | disclosed |
| WO-2002028888-A2 | MIMOTOPE OF NEISSERIA MENINGITIDES LIPOOLIGOSACCHARIDE AND VACCINES CONTAINING THE SAME | GLAXOSMITHKLINE BIOLOGICALS S.A. (BE) | 2002-04-11 | — | — | WO | disclosed |
| WO-2001064008-A2 | VACCINE FOR THE TREATMENT OF ARTHEROSCLEROSIS | SMITHKLINE BEECHAM BIOLOGICALS S.A. (BE) | 2001-09-07 | — | — | WO | disclosed |